Vaccinating The World's Poor
Glaxo is betting it can combat Third World scourges -- and still make money
Source: Business Week
Jean Stephenne is an unlikely revolutionary. The president of GSK Biologicals, the vaccine subsidiary of GlaxoSmithKline PLC (GSK ), is unusually soft-spoken, almost shy. But his gentle demeanor belies a bold risk-taker willing to gamble hundreds of millions of dollars on vaccines to combat diseases in the world's poorest countries.